4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-037553
Chief Financial Officer sold 3,557 shares at $14.65 ($52,097)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2026-02-02 | Sale | −3,557 | $14.65 | $52,097 | 173,547 | D |
| Open-market sales · 3,557 sh · avg $14.65 · $52,097 | |||||||
Loading xslF345X05/ownership.xml…